chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Evening she received shot she became sweaty, dizzy, nauseated and vomited.  Lasted "a few days".  She took over the counter Dramamine which helped.  The vomiting only lasted 1 day- the dizziness lingered.  She denied being evaluated by her PCP.
Chest pain, dyspnea - ongoing. Undergoing evaluation for myocarditis but work up incomplete at this time.
sore arm, headache, body ache, fatigue, joint pain and fever of 103.6 every 4 hours, continue to have fever.
Bad reaction that went over their shoulder; developed a bad reaction in their arm on the site if the injection; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Bad reaction that went over their shoulder) and VACCINATION SITE REACTION (developed a bad reaction in their arm on the site if the injection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION COMPLICATION (Bad reaction that went over their shoulder) and VACCINATION SITE REACTION (developed a bad reaction in their arm on the site if the injection). At the time of the report, VACCINATION COMPLICATION (Bad reaction that went over their shoulder) and VACCINATION SITE REACTION (developed a bad reaction in their arm on the site if the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and Treatment was not specified.
Began with feeling run down, then began with hard chills, developed mouth and nares sores. Saw MD and received Azithromax, Cephalexin for the mouth and nares sores.
12/31/20:left a message saying she got the vaccine 5 days ago and is experiencing severe neck pain that shoots down her neck and back :  saw PCP - f/u 1/8/21 :I still have a little neck pain left and my glands are still slightly swollen. Getting my 2nd dose today. I have paperwork from Pfizer that I need to fill out for their data keeping.  Pain was excruciating for nearly 2wks and started to settle down a few days ago, where I don?t have to sit with a heating pad or take motrin and flexaril.  f/u 1/28/21-"My neck still hurts, worse on certain days, but is bearable. I haven?t had any imaging done and just heard of another person with same symptoms. My 2nd dose was fine. No pain at all, not even at injection site. I will keep you posted if anything changes. I?m hoping it will just go away on it?s own. I?ve heard it takes months".  Referred employee back to PCP.
Fever for 7 days, without Tylenol effectively breaking the fever. After the 7 days, fever would break for around 10 a.m. but spike again around 4:00 p.m. and remain throughout the night. The fever came and went for two weeks. Additionally, I had massive headaches, dizziness, nausea, lack of appetite, and fatigue. I could no longer attend my classes in person and I slept for the majority of the day. The fever subsided around the two week mark, but I continued to have the other symptoms for a month.
The site of administration hurts and has a knot 2 months after the shot was given.
gastrointestinal hemorrhage; It was found to be a diverticula; Flu shot, other vaccine same date vaccine date: 27Sep2021; Flu shot, other vaccine same date vaccine date: 27Sep2021; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the left arm on 27Sep2021 at 11:00 AM (at the age of 67 years old) (Batch/Lot number was not reported) as dose 3 (booster), single for COVID-19 immunisation; and influenza vaccine (INFLUENZA VACCINE), via an unspecified route of administration in the right arm on 27Sep2021 (Batch/Lot number was not reported) at an unknown dose, single for influenza. The patient medical history was not reported. The patient has no known allergies. Concomitant medications included unspecified multiple medications received in two weeks. The patient did not receive other vaccine in four weeks. The patient did not have COVID-19 prior vaccination and had not been tested post-vaccination.  The patient previously received first and second dose of BNT162B2 on 30Jan2021 at 10:00 AM and 20Feb2021 at 10:00 AM respectively, both in the left arm for COVID-19 immunisation at the age of 66-years-old. On 27Sep2021 (time of onset was reported as at 08:00 AM and event onset was also reported as 24 hours after Covid booster and flu shot), the patient experienced gastrointestinal hemorrhage and lost large amount of blood and it was found to be a diverticula. It was also reported that the patient received flu shot the same day (27Sep2021) with BNT162B2 vaccine. The patient had to go to emergency room for resuscitation. The patient was hospitalized for three days. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Treatment was received for the events however it was also reported that the bleeding stopped on its own and treatment for "BP". The events gastrointestinal hemorrhage, and diverticula were reported as serious (hospitalization and life threatening). The outcome of the events gastrointestinal hemorrhage and diverticula were recovering.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
terrible rxn as described by pt to nurse;pt seen by neurologist who said nerve in arm compromised but all studies neg;chart indicated vax given in rt arm,but pt states it was the lt arm;25OCT94 f/u pt cont exp pain & paresthesia in lt arm
NO ADR. Patient was anxious due to needle. He had his vaccine and was asked to sit on chair for 15 minutes. After sitting for 5 minutes, he suddenly fell down from the chair, lying on floor head down. He was anxious and a bit shaky, but conscious of surrounding. He was talking while lying down. Patient refused to call 911 and did not wanted any help. Patient's father was shopping in store and was called to pharmacy. Patient laid down on floor for few minutes and then sat back on chair. After 10 minutes, he was perfectly fine and left the site with his father.
Swelling of lips, no treatment administered, condition ongoing and subsiding as of 4/22/2021.
Patient developed left arm swelling, redness and pain starting about 6 hrs after shot. Patient states it was HPV while our records meningococcal. No respiratory symptoms.
It was reported that a pt rec'd a TD adult and hepatitis B vaccine on 3/3/01. Reportedly between 5-6 pm that same day the pt experienced lower back pain both side and shooting pain down both legs. Only left side now. from additional correspondence rec'd on 9/4/01 it was reported that the pt's recovery status is unknown. This case is closed.
Headache and sore arm immediately after injections. At 2:30 AM following morning my daughter woke up confused distraught, complaining her hands and head felt like they were on fire and she was shuddering with chills. She had a fever of 104.9. I gave her 500 mg ibuprofen. She awoke at 7:00 feverish and chills had temperature of 103. I gave her 500 mg of ibuprofen. At noon she had no fever and no additional medication was given.
Information has been received from a physician concerning a female in her mid 60's who on approximately 15-AUG-2007 was vaccinated with a dose of ZOSTAVAX. On approximately 10-AUG-2008, the patient developed shingles. The patient's outcome was unknown. Medical attention was sought in the physician's office.  Follow up information was received from the physician who reported that the 72 year old patient on 19-JAN-2007 at 1:51 pm was vaccinate dwith her forst dose of ZOSTAVAX (Merck) (lot # 657559/0462U) in the left deltoid. Concomitant therapy included amlodipine, MICARDIS, and unspecified medication and simvastatin. On 08-AUG-2008 the patient developed shingles in the left breast are. At the time of this report, the patient recovered.  Additional information has been requested.  Additional ifnromation is not expected.
Patient developed hives & swelling around injection site expanding 6-8cm. 2 doses of BENADRYL given.
I was having migraine?s the day after the injection (8/7) along with lightheadedness and dizziness for the next several weeks. I was pregnant during the first dose of the injection but didn?t know until a week later after the injection. I went to the emergency room on 8/24/2021 for bleeding, right side abdomen cramps and low back pain. I ended up having emergency surgery that afternoon for a ruptured fallopian tube and ovary on my right side which resulted in a miscarriage at 5 and a half weeks pregnant. This was my second pregnancy as I had a healthy and normal first pregnancy with no issues.
Patient came back to the pharmacy and reported a fever, which is to be expected.  He also has pain, redness and itching of the left eye.  It was recommended that he follow up with his doctor.
This spontaneous report was received from a nurse regarding a 1-year old patient of unknown gender. The patient's concurrent conditions and medical history were not reported. The patient's concomitant therapy included sterile diluent. On an unknown date (reported as 1 year old), the patient was vaccinated with first dose of Oka/Merck VARIVAX (strength, frequency, route, lot # and expiry date was not reported) for prophylaxis. On an unknown date (reported as 2 years old), the patient was vaccinated with second dose of Oka/Merck VARIVAX (strength, frequency, route, lot # and expiry date was not reported) for prophylaxis (inappropriate schedule of drug administration). No adverse effects were reported. No product quality complaint (PQC) was involved.
Achy body, headache, chills, muscle pain, and swollen lymph nodes.
episode of diarrhea; This is a spontaneous report from a contactable consumer. A 78-year-old non-pregnant female received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL9261), via an unspecified route of administration, administered in arm left on an unspecified date (at the age of 78-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, gastrooesophageal reflux disease (GERDS) and hypertension from an unknown date and unknown if ongoing. The patient had other concomitant medications received within 2 weeks of vaccination, reported as 'many'. The second night after vaccination (unspecified date), the patient suddenly had an episode of diarrhea, could not get to the toilet in time. There was no treatment received for the adverse event. The outcome of the event was recovered on an unspecified date.
We have some Moderna COVID-19 vaccine that was given after the expiration date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We have some Moderna COVID-19 vaccine that was given after the expiration date.) in an 81-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No Medical History information was reported.    In October 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (We have some Moderna COVID-19 vaccine that was given after the expiration date.). In October 2021, EXPIRED PRODUCT ADMINISTERED (We have some Moderna COVID-19 vaccine that was given after the expiration date.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not provided. Treatment information was not provided. Date the vial was initially stored in the refrigerator: 24-Sept-2021. Date(s) of administration of vaccine: 24Oct2021 - 27Oct2021.
pressure like pain to right arm, feels like she cannot stretch arm, right forearm and right fingers are tingling, right pinky finger numb-ish, dizziness, nausea
Patient began to experience nausea, followed by chest tightness, sweatiness, tingling in mouth and toes. Vitals were taking by nurse on sight BP was elevated, heart rate was normal, and respiration was labored.  Patient also began to experience difficulty breathing once EMS arrived.
fever; lower back pain; headache; arm pain at injection site; generalized aches; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (lower back pain), HEADACHE (headache), INJECTION SITE PAIN (arm pain at injection site), PAIN (generalized aches) and PYREXIA (fever) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced BACK PAIN (lower back pain), HEADACHE (headache), INJECTION SITE PAIN (arm pain at injection site) and PAIN (generalized aches). On 08-Jan-2021, the patient experienced PYREXIA (fever). At the time of the report, BACK PAIN (lower back pain), HEADACHE (headache), INJECTION SITE PAIN (arm pain at injection site), PAIN (generalized aches) and PYREXIA (fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, Pyrexia: 99.9 degree F This morning and 100.4 degree F This morning.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
High fever - 103.4 F, severe body aches, nausea, chills, fatigue, severe headache, painful shoulder, severe pruritis at injection site and in surrounding tissues- from joint at shoulder down to elbow. Continued pruritis and increased and spreading erythema for approximately 14 days post vaccine.
Shingles; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the a left arm on 29Mar2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any concomitant medications. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:EN6206) via an unspecified route of administration in the left arm on 08Mar2021 at 17:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 09:00, the patient experienced shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with anti viral medication and pain medication. The clinical outcome of the event shingles was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient Received her second dose Pfizer (LOT#: EW0172 EXP: 8/2021) at 1224 on 4/23/21. Patient had bad anxiety attack during her first dose. PHN decided to stay with patient for a little. Patient requested husband to stay with her. 5 minutes into observation patient started exhibiting similar signs to her last anxiety attack. Patient used coping mechanisms to relax. PHN offered patient some juice. patient accepted the juice. PHN also stayed with patient to make sure she was alert and oriented. EMT took vital signs and vital signs were normal. Patient finished 30 minute observation. Patient walked out of vaccination area with a steady gait with her husband.
On 3/4/2021 I was diagnosed with metastatic lung cancer which further studies showed that there were innumerable bone and organ metastases.  On 3/12/2021 I was further diagnosed with multiple pulmonary emboli.
Red; Hurt; lymph nodes swelling under breast in the same side of the injection; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red), PAIN (Hurt), LYMPHADENOPATHY (lymph nodes swelling under breast in the same side of the injection), MYALGIA (body aches) and PYREXIA (fever) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red), PAIN (Hurt), LYMPHADENOPATHY (lymph nodes swelling under breast in the same side of the injection), MYALGIA (body aches) and PYREXIA (fever). At the time of the report, ERYTHEMA (Red), PAIN (Hurt), LYMPHADENOPATHY (lymph nodes swelling under breast in the same side of the injection), MYALGIA (body aches) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) 102F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Parent called on 7-28-11 & said patient's (R) arm was red & slightly swollen. Pain level 4-5 on scale. Recommended cold compresses & TYLENOL.
Dizziness; Injection site itching; Injection site swelling; Injection site redness; Headache; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), DIZZINESS (Dizziness), INJECTION SITE PRURITUS (Injection site itching), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE ERYTHEMA (Injection site redness) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). On 24-Feb-2021, the patient experienced DIZZINESS (Dizziness), INJECTION SITE PRURITUS (Injection site itching), INJECTION SITE SWELLING (Injection site swelling), INJECTION SITE ERYTHEMA (Injection site redness) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Pain in arm), DIZZINESS (Dizziness), INJECTION SITE PRURITUS (Injection site itching), INJECTION SITE SWELLING (Injection site swelling), INJECTION SITE ERYTHEMA (Injection site redness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient have a event like injection site sore.   Most recent FOLLOW-UP information incorporated above includes: On 25-Feb-2021: follow up added
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 27-AUG-2014 the patient was vaccinated with a dose of improperly stored (Oka/Merck) VARIVAX (route and dose not reported, lot # K002925, expiration date 26-FEB-2016). It was reported that the excursion for the (Oka/Merck) VARIVAX in question was found to be supported with in-house stability data. No adverse symptoms reported. This is one of several reports from the same source. Additional information has been requested.
Patient had the following symptoms: fever (up to 102.4), screaming inconsolably, arching back with screaming, vomiting, not eating/drinking, restless, lethargic, and has diarrhea.  Patient was sent to ER for further evaluation on 10/23/2020, and then was sent to hospital for IV fluids and additional testing.  Patient stayed in hospital for 1 day and was discharged.
I had a sore throat, cough low grade fever,  I took a home COVID-19 test that came back positive. I called my doctor who called in a prescription of Paxlovid. I felt good after a few days. Then I had rebound symptoms and the fatigue had increased more than before. I went in to see my doctor for a follow up visit from a surgery and I still felt the fatigue. My doctor feels that I am on the mend.
A 57 year old female patient with no significant medical history, and who had received the flu vaccine for the past three years with no reaction, had received an intramuscular injection of Fluzone SV 2005-2006 USP, lot number U17622AA, in the left arm in 02/Nov/2005 at 12:15 pm. the next day the patient developed a headache that became more severe in nature on04/Nov/2005. ON 04/Nov/2005 she developed swelling in her hands, arms, legs and ankles. This was accompanied by pain the the joints. She went to the ER and was treated with steroids. The patient had recovered from these even at the time of this report.
CENTRAL SLEEP APNEA IN CONDITIONS CLASSIFIED ELSEWHERE 10/25/2021 AMYLOIDOSIS, UNSPECIFIED CENTRAL SLEEP APNEA IN CONDITIONS CLASSIFIED ELSEWHERE 10/25/2021 HYPOTENSION CENTRAL SLEEP APNEA IN CONDITIONS CLASSIFIED ELSEWHERE 10/25/2021 BRADYCARDIA
Redness on the shoulder; Itches; Feels heavy; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness on the shoulder), PRURITUS (Itches) and DISCOMFORT (Feels heavy) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced ERYTHEMA (Redness on the shoulder), PRURITUS (Itches) and DISCOMFORT (Feels heavy). At the time of the report, ERYTHEMA (Redness on the shoulder), PRURITUS (Itches) and DISCOMFORT (Feels heavy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.